Search Results - Fabrizio Schifano

2023: The Best Year Ever for <i>Future Pharmacology</i> (and Even Better Years to Come) by Fabrizio Schifano

Connect to this object online.

Recent Changes in Drug Abuse Scenario: The Novel Psychoactive Substances (NPS) Phenomenon by Fabrizio Schifano (Ed.)

DOAB: download the publication
DOAB: description of the publication

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues by Stefania Chiappini, Fabrizio Schifano

Connect to this object online.

Is There a Potential of Misuse for Venlafaxine and Bupropion? by Fabrizio Schifano, Stefania Chiappini

Connect to this object online.

Role of patient-reported outcomes and other efficacy endpoints in the drug approval process in Europe (2008-2012) by Dipika Bansal, Anil Bhagat, Fabrizio Schifano, Kapil Gudala

Connect to this object online.

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites. by Imanollah Bigdeli, Ornella Corazza, Zoe Aslanpour, Fabrizio Schifano

Connect to this object online.

Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems by Fabrizio Schifano, Stefania Chiappini, John Martin Corkery, Amira Guirguis

Connect to this object online.

Psilocybin for Depression: From Credibility to Feasibility, What's Missing? by Antonio Munafò, Davide Arillotta, Guido Mannaioni, Fabrizio Schifano, Renato Bernardini, Giuseppina Cantarella

Connect to this object online.

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases by Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano

Connect to this object online.

The Psychonauts' Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity by Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum, Fabrizio Schifano

Connect to this object online.

Knowledge of, and attitude towards, the treatment of hepatitis C in people who inject drugs by Patrik Roser, Mona Brunstein, Michael Specka, Jörg Timm, Stefan Kühnhold, Fabrizio Schifano, Udo Bonnet, Norbert Scherbaum

Connect to this object online.

Overview of literature and information on "khat-related" mortality: a call for recognition of the issue and further research by John M. Corkery, Fabrizio Schifano, Adenekan Oyefeso, A. Hamid Ghodse, Thomy Tonia, Vinesha Naidoo, Jennifer Button

Connect to this object online.

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported... by Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John M. Corkery, Giovanni Martinotti, Daniel R. Harris, Fabrizio Schifano

Connect to this object online.

Semaglutide as a Possible Calmodulin Binder: Ligand-Based Computational Analyses and Relevance to Its Associated Reward and Appetitive Behaviour Actions by Giuseppe Floresta, Davide Arillotta, Valeria Catalani, Gabriele Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Fabrizio Schifano

Connect to this object online.

Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse by Alessandro E. Vento, Fabrizio Schifano, Federica Gentili, Francesco Pompei, John M. Corkery, Georgios D. Kotzalidis, Paolo Girardi

Connect to this object online.

Could Cariprazine Be a Possible Choice for High Functioning Autism? A Case Report by Andrea Miuli, Carlotta Marrangone, Ornella Di Marco, Arianna Pasino, Gianfranco Stigliano, Alessio Mosca, Mauro Pettorruso, Fabrizio Schifano, Giovanni Martinotti

Connect to this object online.

Can reinforcement-based interventions to reduce drug use successfully be adapted to routine opioid maintenance treatment? by Michael Specka, Antje Böning, Jürgen Kluwig, Fabrizio Schifano, Markus Banger, Wolfgang Lange, Hildegard Lax, Bärbel Marrziniak, Claudia Schüngel, Norbert Scherbaum

Connect to this object online.

Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques by Anthony Mullin, Mark Scott, Giorgia Vaccaro, Giuseppe Floresta, Davide Arillotta, Valeria Catalani, John M. Corkery, Jacqueline L. Stair, Fabrizio Schifano, Amira Guirguis

Connect to this object online.

Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset by Stefania Chiappini, Rachel Vickers-Smith, Daniel Harris, G. Duccio Papanti Pelletier, John Martin Corkery, Amira Guirguis, Giovanni Martinotti, Stefano L. Sensi, Fabrizio Schifano

Connect to this object online.

Club Drugs and Psychiatric Outcomes: A Descriptive Case Series from Spain by Chiara Montemitro, Alessio Mosca, Stefania Chiappini, Andrea Miuli, Fabrizio Schifano, Maria Josè Gordillo Montano, Cristina Merino del Villar, Rita Allegretti, Carlotta Marrangone, Gilberto Di Petta, Domenico De Berardis, Mauro Pettorruso, Giovanni Martinotti

Connect to this object online.